Before starting, readers should: Verify service availability in their state Confirm clinician licensure in their state Verify pharmacy credentials and licensing Understand that privacy practices vary by provider and pharmacy Understand the regulatory differences between compounded and FDA-approved medications Review FDA safety communications about compounded GLP-1 products Questions for the Provider If you proceed through the intake process and are connected with a provider, questions worth asking include: Which compounding pharmacy prepares the medications
while another said it was like the grapefruit-flavored soft drink Fresca or "Sprite with some hints of Skittles, grapefruit, and lemon." Another Redditor skips the mention of citrus altogether and pronounces the beverage's flavor as a mixture of bubblegum and white grape, highlighting the lack of consensus
Adult Patients without Type 2 Diabetes In SAXENDA clinical trials in adult patients without type 2 diabetes mellitus, there was no systematic capturing or reporting of hypoglycemia
If youre a payer, employer or provider navigating the GLP-1 revolution, dont rely solely on published trials
Zhang M, Niu W, Wang Y, et al
